Variable . | DCCT baseline . | DCCT closeout . | EDIC years 13–14 . |
---|---|---|---|
Clinical neuropathy | |||
INT | 57/600 (10) | 57/533 (11)† | 145/505 (29) |
CONV | 48/581 (8) | 96/526 (18) | 154/448 (34) |
Abnormal NCSs | |||
INT | 185/601 (31) | 73/410 (18)† | 195/430 (45) |
CONV | 196/582 (34) | 137/382 (36) | 151/290 (52) |
Confirmed clinical neuropathy | |||
INT | 39/600 (7) | 32/551 (6)† | 117/541 (22) |
CONV | 31/581 (5) | 75/543 (14) | 136/479 (28)‡ |
Variable . | DCCT baseline . | DCCT closeout . | EDIC years 13–14 . |
---|---|---|---|
Clinical neuropathy | |||
INT | 57/600 (10) | 57/533 (11)† | 145/505 (29) |
CONV | 48/581 (8) | 96/526 (18) | 154/448 (34) |
Abnormal NCSs | |||
INT | 185/601 (31) | 73/410 (18)† | 195/430 (45) |
CONV | 196/582 (34) | 137/382 (36) | 151/290 (52) |
Confirmed clinical neuropathy | |||
INT | 39/600 (7) | 32/551 (6)† | 117/541 (22) |
CONV | 31/581 (5) | 75/543 (14) | 136/479 (28)‡ |
Data are n (%).
†P < 0.001 former intensive treatment group (INT) vs. former conventional treatment group (CONV).
‡P = 0.125.